Cargando…
Pharmacological treatment of presbyopia: A systematic review
The aim of this study was to identify the efficacy of drug agents for pharmacological Treatment of Presbyopia. Published research papers were reviewed using the relevant terms in PubMed, Science direct, Google scholar, Medline, Google patent, Ovid, Cochrane Database of Systematic Reviews, Scopus. In...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580536/ https://www.ncbi.nlm.nih.gov/pubmed/36121117 http://dx.doi.org/10.4081/ejtm.2022.10781 |
_version_ | 1784812409141067776 |
---|---|
author | Haghpanah, Negin Alany, Raid |
author_facet | Haghpanah, Negin Alany, Raid |
author_sort | Haghpanah, Negin |
collection | PubMed |
description | The aim of this study was to identify the efficacy of drug agents for pharmacological Treatment of Presbyopia. Published research papers were reviewed using the relevant terms in PubMed, Science direct, Google scholar, Medline, Google patent, Ovid, Cochrane Database of Systematic Reviews, Scopus. In the initial search, 2270 records were obtained. By removing duplicate articles and all articles that did not meet the inclusion criteria or were inappropriate due to indirect relevance to the subject, 44 studies were selected. It should be noted that all studies had inclusion criteria. There are a number of topical pharmacological agents available for treating presbyopia such as FOV Tears and PresbiDrop. They consist of parasympathetic agent and non-steroidal anti-inflammatory drugs (NSAIDs), to contract the ciliary and pupil muscle and restore the accommodation. Another example of topical pharmacological agent is EV06. It is a lens-softening eye drop which can affect the rigid lens in presbyopia. Currently there is no pharmacological agent available to treat presbyopia. Although there are limited number of peer-reviewed articles available, the outcome for future agents under investigation are promising. |
format | Online Article Text |
id | pubmed-9580536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-95805362022-10-20 Pharmacological treatment of presbyopia: A systematic review Haghpanah, Negin Alany, Raid Eur J Transl Myol Article The aim of this study was to identify the efficacy of drug agents for pharmacological Treatment of Presbyopia. Published research papers were reviewed using the relevant terms in PubMed, Science direct, Google scholar, Medline, Google patent, Ovid, Cochrane Database of Systematic Reviews, Scopus. In the initial search, 2270 records were obtained. By removing duplicate articles and all articles that did not meet the inclusion criteria or were inappropriate due to indirect relevance to the subject, 44 studies were selected. It should be noted that all studies had inclusion criteria. There are a number of topical pharmacological agents available for treating presbyopia such as FOV Tears and PresbiDrop. They consist of parasympathetic agent and non-steroidal anti-inflammatory drugs (NSAIDs), to contract the ciliary and pupil muscle and restore the accommodation. Another example of topical pharmacological agent is EV06. It is a lens-softening eye drop which can affect the rigid lens in presbyopia. Currently there is no pharmacological agent available to treat presbyopia. Although there are limited number of peer-reviewed articles available, the outcome for future agents under investigation are promising. PAGEPress Publications, Pavia, Italy 2022-09-19 /pmc/articles/PMC9580536/ /pubmed/36121117 http://dx.doi.org/10.4081/ejtm.2022.10781 Text en https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Haghpanah, Negin Alany, Raid Pharmacological treatment of presbyopia: A systematic review |
title | Pharmacological treatment of presbyopia: A systematic review |
title_full | Pharmacological treatment of presbyopia: A systematic review |
title_fullStr | Pharmacological treatment of presbyopia: A systematic review |
title_full_unstemmed | Pharmacological treatment of presbyopia: A systematic review |
title_short | Pharmacological treatment of presbyopia: A systematic review |
title_sort | pharmacological treatment of presbyopia: a systematic review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580536/ https://www.ncbi.nlm.nih.gov/pubmed/36121117 http://dx.doi.org/10.4081/ejtm.2022.10781 |
work_keys_str_mv | AT haghpanahnegin pharmacologicaltreatmentofpresbyopiaasystematicreview AT alanyraid pharmacologicaltreatmentofpresbyopiaasystematicreview |